木瓜直播

Absolute risk remains low, however

Trials now enroll lower-risk women who get better treatment, analysis suggests

Adding inavolisib to palbociclib/fulvestrant more than doubled PFS in endocrine-resistant disease

News, features, and commentary about cancer-related issues

Bladder, brain, and cervical cancer risks were higher in people with MS

Health news and commentary gathered by 木瓜直播 staff

Higher risk for ever use, increasing duration of use but no increase in BRCA2 carriers

News, features, and commentary about cancer-related issues

Health news and commentary gathered by 木瓜直播 staff

Trial finds similar complication and recurrence rates with hypofractionated versus standard RT

Numerical advantage in randomized trial, non-randomized study misses noninferiority mark

Study suggests differences in how the ACA cost-sharing exemption is applied across patient groups

News, features, and commentary about cancer-related issues

Actual rates for 2021 lagged behind projections